Cite
HARVARD Citation
Moser, S. et al. (n.d.). Efficacy of ledipasvir/sofosbuvir plus ribavirin for 12 weeks in patients with chronic hepatitis C genotype 3 and compensated liver disease. European journal of gastroenterology & hepatology. 30 (3), p. . [Online].